Stratus Properties Inc. Reports Second-Quarter and Six-Month 2024 Results
Contacts Financial and Media Contact: William H. Armstrong III (512) 478-5788 Stratus Properties Inc. (NASDAQ: STRS), a residential and retail...
PR News
Star Equity Holdings, Inc. Announces 2024 Second Quarter Financial Results
Timber Technologies acquisition marks major Company milestone; diversifies Building Solutions division revenue streams and improves Star’s overall cash flow and...
Star Equity Holdings, Inc. Announces 2024 Second Quarter Financial Results
Timber Technologies acquisition marks major Company milestone; diversifies Building Solutions division revenue streams and improves Star’s overall cash flow and...
SOPHiA DDM™ Platform Certified Under IVDR
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets BOSTON and ROLLE, Switzerland, Aug. 14, 2024 /PRNewswire/...
Smart Sand, Inc. Announces Second Quarter 2024 Results
YARDLEY, Penn., Aug. 13, 2024 /PRNewswire/ -- Smart Sand, Inc. (NASDAQ: SND) (the "Company" or "Smart Sand"), a fully integrated...
Sidus Space Secures Contract with Xiomas Technologies to Supply FeatherEdge Computing System for Fire Detection via High-Altitude Infrared Imaging
FeatherEdge Computing System to Enhance Rapid Fire Detection Capabilities in Collaborative NASA Project Contacts Investor Relations investorrelations@sidusspace.com Media Inquiries press@sidusspace.com...
Shimmick Corporation Announces Updated Second Quarter 2024 Earnings Conference Call Date
IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Shimmick Corporation (“Shimmick”) (Nasdaq: SHIM), a leading water infrastructure company, today updated...
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic...
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the...
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
Redfin Reports Asking Rents Fall Across All Bedroom Counts for First Time in 4 Years
The nationwide median asking rent was $1,647 in July, down $53 from the all-time high in 2022 Contacts Redfin Journalist...
Ribbon CFO Mick Lopez to Retire in 4th Quarter 2024
PLANO, Texas, Aug. 13, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and...
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to “BGM”
CHENGDU, China, Aug. 13, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: QLI), a China-based...
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Approximately 320 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site InfectionsRead...
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
Plus’ CNSide leptomeningeal metastases (LM) FORSEE trial met key primary and secondary endpointsCNSide more than doubled the diagnostic sensitivity vs....
Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
Global tubeless insulin pump technology leader officially commences manufacturing of Omnipod® 5 Automated Insulin Delivery System at new facility, enabling...
PodcastOne (Nasdaq: PODC) Reports Q1 FY 2025 Record Revenue of $13.2M (+25% YoY)
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading podcast platform and a subsidiary of LiveOne (Nasdaq: LVO),...
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
PITTSBURGH, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and...
CPI Card Group, Cypris Materials Recognized with a Sustainability Initiative of the Year Award
CYPRIS™ structural color ink sets new eco-friendly standard in card printing Contacts Media Contact: Andy Sedlak Dix & Eaton media@cpicardgroup.com...
Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update
ZUG, Switzerland, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2...
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage...
The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer
Request for insurance coverage aims to enhance early detection and treatment of esophageal precancer to prevent highly lethal esophageal cancer...
MICHEL GERMAIN PARFUMS LTD Announces Collaboration with Paramount Consumer Products for Emily in Paris Prestige Fragrance
NEW YORK, Aug. 14, 2024 /PRNewswire/ - Prestige fragrance house Michel Germain Parfums is thrilled to announce a partnership with...
Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
– Continued progress toward commencement of Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of...
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2024 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2024
GREENWHICH, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,”...
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2024 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2024
GREENWHICH, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,”...
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2024 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2024
GREENWHICH, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,”...
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to improving the...
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
ISELIN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that has achieved regulatory...
Ondas Secures Expansion of its Initial Purchase Order of Iron Drone Raider Systems Received from a Major Military Customer for Immediate Deployment
Expansion of initial purchase order received from a government military customer reflects the urgent need for Ondas' innovative counter-drone system...
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
CAMBRIDGE, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a biotechnology company pioneering the development...
The ODP Corporation Announces Departure of Chief Financial Officer
D. Anthony Scaglione to pursue another career opportunity Contacts Tim Perrott Investor Relations 561-438-4629 Tim.Perrott@theodpcorp.com The ODP Corporation (“ODP,” or...
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
VEGA-3 Phase 3 Study of Phentolamine Ophthalmic Solution in Presbyopia is Recruiting Patients with Top-Line Data Expected in 2025LYNX-2 Phase...
Realtor.com® 2024 Forecast Update: Mortgage Relief is Finally on the Way
Buoyed by a Strong U.S. Economy, For Sale Inventory and the Existing Home Median Sales Price are Now Expected to...
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
Contacts INVESTORS: Ingrid Goldberg investorinfo@novocure.com MEDIA: Catherine Falcetti media@novocure.com Novocure (NASDAQ: NVCR) today announced its participation in the upcoming International...
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives...
NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
No Significant Issues Encountered During the Single Ascending Dose (SAD) Study, Allowing for Previously Reported Accelerated Start to Multiple Ascending...
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics...
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
This press release was updated to reflect the correct dosing schedule of the NKX019 investigator-sponsored clinical trial. As previously disclosed,...
NICE Named a Leader and Star Performer in Everest Group’s 2024 Conversational AI Products PEAK Matrix Assessment
NICE scored high on both ‘Vision and Capability’ as well as the ‘Market Impact’ axis in leading analyst's Conversational AI...